sirolimus has been researched along with Fibroma* in 3 studies
3 other study(ies) available for sirolimus and Fibroma
Article | Year |
---|---|
Successful treatment of subungual fibromas of tuberous sclerosis with topical rapamycin.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Female; Fibroma; Humans; Infant; Nail Diseases; Remission Induction; Sirolimus; Skin Neoplasms; Tuberous Sclerosis | 2014 |
Familial multiple discoid fibromas: unique histological features and therapeutic response to topical rapamycin.
Familial multiple discoid fibromas is a rare genodermatosis that bears some resemblance to Birt-Hogg-Dubé syndrome but is not associated with mutations in the folliculin (FLCN) gene or systemic manifestations. It is characterized by the development of papules over the face and pinnae early in life. Histological findings are of fibrovascular tumours adjacent to hair follicles without features characteristic of fibrofolliculomas, which have recently been termed discoid fibromas. We present siblings with multiple papules over the face and pinnae that developed in childhood. Histological specimens from both siblings demonstrated discoid fibromas, but with some lesions exhibiting an unusual keloidal-like pattern with thick hyalinized collagen fibres surrounded by plump spindle and histiocyte-like cells. FLCN gene mutations were not found. We report on clinical improvement with topical rapamycin solution (1 mg mL(-1)) applied daily to the face for 4 months. Therapeutic response to topical rapamycin may provide a clue to the underlying genetic basis of this condition. Topics: Administration, Cutaneous; Adult; Antibiotics, Antineoplastic; Facial Neoplasms; Female; Fibroma; Humans; Male; Sirolimus; Skin Neoplasms; Treatment Outcome; Young Adult | 2013 |
Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex.
A male with tuberous sclerosis complex (TSC) developed a chest wall fibromatosis and bilateral multifocal renal cell carcinoma (RCC). The fibromatosis tumor was initially resected during infancy but recurred 5 years later. At that time, bilateral RCC was also detected, leading to the resection of the more extensively affected right kidney. In an attempt to avoid bilateral nephrectomies, the patient was treated with the mTOR inhibitor sirolimus. Within 6 months of therapy, the fibromatosis and remaining RCC tumors responded substantially with minimal adverse effects. Topics: Antibiotics, Antineoplastic; Carcinoma, Renal Cell; Child; Fibroma; Humans; Kidney Neoplasms; Loss of Heterozygosity; Male; Sirolimus; Thoracic Wall; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2010 |